Title:
A PHARMACEUTICAL COMPOSITION FOR REGULATING THE POTASSIUM CHANNEL IN CARDIAC MUSCLE CELL AND ITS PREPARATION METHOD AND ITS USES
Document Type and Number:
WIPO Patent Application WO/2010/009573
Kind Code:
A1
Abstract:
A pharmaceutical composition for regulating the potassium channel in cardiac muscle cell, its preparation method and its uses. The pharmaceutical composition consists of ginseng 45-180 parts, ophiopogonis 50-200 parts, corni 125-450 parts, miltiorrhizae 125-450 parts, fried spinosae 95-400 parts, taxilli 95-400 parts, rubra 45-200 parts, steleophaga 35-150 parts by weight.
Inventors:
PU JIELIN (CN)
LI NING (CN)
MA KEJUAN (CN)
LI NING (CN)
MA KEJUAN (CN)
Application Number:
PCT/CN2008/001357
Publication Date:
January 28, 2010
Filing Date:
July 23, 2008
Export Citation:
Assignee:
HEBEI YILING MEDICINE RES INST (CN)
PU JIELIN (CN)
LI NING (CN)
MA KEJUAN (CN)
PU JIELIN (CN)
LI NING (CN)
MA KEJUAN (CN)
International Classes:
A61K36/8968; A61K9/00; A61K35/02; A61K35/64; A61K36/258; A61K36/53; A61K36/71; A61P9/06
Foreign References:
| CN1188159C | 2005-02-09 | |||
| CN1188159C | 2005-02-09 | |||
| CN101234169A | 2008-08-06 | |||
| CN101313990A | 2008-12-03 |
Other References:
ZHOU, YU-PING ET AL.: "The effect of Shensongyangxin capsule on clinical symtoms and HOU, Yu-ping, The effect of Shensongyangxin capsule on clinical symtoms and ECG in patients with paroxysmal atrial fibrillation", CHIN J DIFFIC AND COMPL CAS, vol. 6, no. 2, February 2007 (2007-02-01), pages 65 - 67
Attorney, Agent or Firm:
BEIJING GOLDEN BRIDGE IP AGENCY CO., LTD (Horizon International Tower No.6 Zhichun Road Haidian, Beijing 8, CN)
Download PDF:
Previous Patent: NEW LOW SIDE EFFECT PHARMACEUTICAL COMPOSITION CONTAINING ISONIAZID
Next Patent: METHOD FOR DISTRIBUTING SOFTWARE IN A LIGHTING SYSTEM
Next Patent: METHOD FOR DISTRIBUTING SOFTWARE IN A LIGHTING SYSTEM